Retireful LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, Holdings Channel.com reports. The fund acquired 6,214 shares of the company’s stock, valued at approximately $3,001,000. Astera Labs accounts for approximately 2.9% of Retireful LLC’s holdings, making the stock its 7th largest holding.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ALAB. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter valued at about $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the second quarter worth about $25,000. Archer Investment Corp acquired a new stake in Astera Labs in the second quarter worth about $30,000. Smartleaf Asset Management LLC grew its stake in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs during the fourth quarter valued at about $33,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
ALAB has been the subject of several research analyst reports. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Morgan Stanley upped their price target on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Finally, Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $348.33.
Astera Labs Stock Down 2.1%
Shares of NASDAQ ALAB opened at $274.13 on Thursday. The business’s 50 day moving average price is $334.67 and its 200 day moving average price is $252.89. The firm has a market cap of $47.56 billion, a P/E ratio of 135.71 and a beta of 3.77. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period last year, the firm posted $0.44 EPS. Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Insider Transactions at Astera Labs
In related news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 396,745 shares of company stock valued at $155,029,458. 10.40% of the stock is owned by corporate insiders.
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
